Clinical Trial Update: A Phase III Study of Postoperative Early Temozolomide Treatment Plus STUPP Regimen for Newly Diagnosed GBM Multiforme [Phase 3]

View source ↗

Summary

Phase III study investigating postoperative early temozolomide with the STUPP regimen for newly diagnosed glioblastoma multiforme; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Oligoastrocytoma
• Glioblastoma

Drugs mentioned

• Temozolomide (Temozolomide)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Anaplastic Oligoastrocytoma, Glioblastoma | Phase 3 | Status: UNKNOWN